Deutsche Märkte geschlossen

Cryofocus Medtech (Shanghai) Co., Ltd. (6922.HK)

HKSE - HKSE Verzögerter Preis. Währung in HKD
Zur Watchlist hinzufügen
7,600-0,140 (-1,81%)
Börsenschluss: 03:21PM HKT

Cryofocus Medtech (Shanghai) Co., Ltd.

Building 15
Lane 3399 Kangxin Road Pudong New Area
Shanghai 200120
China
86 21 2097 7850
https://www.cryofocus.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter392

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Kejian LiExecutive Chairman of the BoardN/AN/A1969
Mr. Jun ZhuGM & Executive Director2,78MN/A1975
Mr. Wei LiuCFO, Joint Company Secretary & Executive Director1,22MN/A1991
Dr. Kuiwen ZhaoTechnical Director and R&D ManagerN/AN/A1983
Dr. Jihong QuChief Medical OfficerN/AN/A1963
Mr. Zhimin ChenExecutive Vice President of Ningbo SensCureN/AN/A1984
Ms. Wai Yan LeungJoint Company SecretayN/AN/AN/A
Mr. Yuepeng DiaoDeputy Vice PresidentN/AN/A1984
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in HKD.

Beschreibung

Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, develops, produces, and sells minimally-invasive interventional cryotherapy products in the People's Republic of China. The company develops products in the areas of vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases. Its products include Bladder Cryoablation System, a cryotherapy device for the treatment of non-muscle-invasive bladder cancer; pulmonary nodule localization needle for CT-guided localization of lung nodules; endoscopic clip for anastomosis for the closure of soft tissue in digestive tract; and laparoscopic single port multi-channel access platform for laparoscopic surgery. The company's products also comprise wound retractors for small incision surgery and minimally invasive surgery; ureteral dilation balloon catheter for ureteral stricture; laparoscopic biopsy bag for biopsy; and laparoscopic surgical instrument for laparoscopy application. The company was incorporated in 2013 and is based in Shanghai, the People's Republic of China.

Corporate Governance

Cryofocus Medtech (Shanghai) Co., Ltd.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.